Built-in safeguards might stop AI from designing bioweapons
Researchers propose modifying protein-design algorithms to keep bad actors from misusing them
Related Articles
Ice age couture: Ancient people tailored form-fitting clothing from reindeer pelts
Trove of artifacts from 20,000-year-old campsite provides strongest direct evidence for custommade winter clothing
The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness
Polymeric Borrelia burgdorferi peptidoglycan cell wall can persist in murine livers for weeks to months after direct injection or infection.
How I regained my confidence as a scientist through rowing
“It was hard to see myself in a field in which so few people from my background were represented,” this Ph.D. student writes
Vietnam War’s survivors shed light on the long-term tolls of military conflict
Researchers are working with people who lived through the war as teenagers to understand conflict’s long-term tolls
Structural robustness and temporal vulnerability of the starvation-responsive metabolic network in healthy and obese mouse liver
A metabolic network based on omic data reveals how obesity affects how the liver adapts to starvation.
Complete Genomics and Velsera Partner to Integrate Sequencing and Analysis Platforms
Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to insight.
A notorious performance-enhancing hormone helps tumors hide from the immune system
Blocking erythropoietin’s effects on macrophages fights cancer in mice
Partisan disparities in the use of science in policy
Documents from Congress and think tanks reflect differences in how science is cited
NIH insiders: Trump is ‘dismantling and destroying everything’
After just 100 days, agency scientists say U.S. health institutes are demoralized and have lost essential staff and funding
Injectable Protein-Like Polymers Protect Rodent Heart After Myocardial Infarction
A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within the cells.